Peptides that support muscle growth primarily work through the growth hormone (GH) and insulin-like growth factor (IGF) axis, stimulating the body's own anabolic signaling rather than directly activating androgen receptors like anabolic steroids. This distinction matters: peptide-mediated muscle growth tends to be more gradual and works in concert with natural hormonal rhythms.
The peptides in this guide span several mechanistic categories — GH secretagogues that stimulate pituitary release, IGF-1 analogs that act directly on muscle tissue, and myostatin inhibitors that remove a biological brake on muscle growth. Each has a different evidence base, ranging from peptides with published human data to those supported primarily by preclinical research.
Important: None of these peptides are FDA-approved for muscle building or bodybuilding purposes. Several are prescription medications approved for other conditions (e.g., GH deficiency), and others are research compounds. This guide is for educational purposes only. Muscle-building goals should be pursued through proven methods — progressive resistance training and adequate nutrition — with any peptide use discussed with a qualified healthcare provider.
IGF-1 LR3
Best for: Direct IGF-1 receptor-mediated anabolic signaling (advanced research use only)
IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1 with an extended half-life of approximately 20-30 hours compared to native IGF-1's minutes. It directly stimulates muscle cell proliferation and differentiation through the IGF-1 receptor, making it the most directly anabolic peptide on this list. Its potency also carries higher risk, including potential hypoglycemia and concerns about uncontrolled cell growth.
CJC-1295
Best for: Sustained GH elevation with convenient weekly dosing (GHRH pathway)
CJC-1295 is a GHRH analog that stimulates sustained growth hormone release from the pituitary. The DAC (Drug Affinity Complex) variant has a half-life of 6-8 days, enabling weekly dosing. By elevating GH, it indirectly raises IGF-1 levels, supporting muscle protein synthesis, recovery, and body composition improvement over time.
Ipamorelin
Best for: Clean, selective GH release with minimal hormonal side effects
Ipamorelin is a selective ghrelin receptor agonist that stimulates pulsatile GH release with minimal impact on cortisol, prolactin, or appetite — making it one of the cleanest GH secretagogues available. It is commonly paired with CJC-1295 for synergistic GH release. Its selectivity makes it well-tolerated but its GH-elevating effect is more moderate than some alternatives.
MK-677
Best for: Oral convenience with sustained GH/IGF-1 elevation (no injections needed)
MK-677 (ibutamoren) is an oral GH secretagogue that elevates GH and IGF-1 levels for up to 24 hours per dose. Its oral bioavailability eliminates the need for injections, making it the most convenient option. Published human studies demonstrate sustained IGF-1 elevation. However, it significantly increases appetite and can affect insulin sensitivity, which may be counterproductive for some goals.
Follistatin-344
Best for: Myostatin inhibition approach to removing natural muscle growth limits (early research)
Follistatin-344 binds and neutralizes myostatin, a protein that limits muscle growth. By removing this biological brake, follistatin-344 can theoretically allow greater muscle hypertrophy than the body's natural ceiling. Animal studies show dramatic muscle mass increases in myostatin-knockout models. However, human data is extremely limited, and long-term safety of myostatin inhibition is unknown.
MGF
Best for: Localized satellite cell activation at the site of muscle damage
Mechano Growth Factor (MGF) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical damage from exercise. It activates satellite cells — muscle stem cells — to repair and grow damaged fibers. Its extremely short half-life (minutes) limits practical utility unless used in the PEGylated form (PEG-MGF).
PEG-MGF
Best for: Extended-duration satellite cell activation with systemic reach
PEG-MGF is the PEGylated version of Mechano Growth Factor, engineered to extend its half-life from minutes to several hours. This makes systemic administration practical. It supports satellite cell activation and muscle repair, but evidence remains primarily preclinical. It is typically used as an adjunct to other GH-releasing peptides rather than as a standalone.
Sermorelin
Best for: Physiological GH restoration with prior FDA-approval safety history
Sermorelin is a GHRH analog that was previously FDA-approved (as Geref) for diagnosing GH deficiency. It stimulates physiological, pulsatile GH release and is commonly used in age-management and anti-aging protocols. Its GH-elevating effect is more modest than CJC-1295 or ipamorelin/CJC-1295 combinations, but its prior FDA approval provides a degree of safety validation that newer compounds lack.
Frequently asked questions
Peptides that elevate growth hormone and IGF-1 can support muscle protein synthesis, recovery, and body composition improvement. However, their anabolic effect is indirect and more gradual compared to androgens. Clinical studies of GH-elevating peptides show modest improvements in lean body mass, particularly in GH-deficient populations. They are not a substitute for progressive resistance training and adequate protein intake.
Legality varies by compound and jurisdiction. MK-677 is not a controlled substance in most countries but is not FDA-approved. Sermorelin has prior FDA-approval history. IGF-1 LR3, follistatin-344, MGF, and PEG-MGF are research compounds without FDA approval. Several peptides are banned by WADA and most sports organizations. Legal status should be verified for your jurisdiction and intended use.
The most commonly discussed muscle growth stack combines CJC-1295 with ipamorelin to stimulate GH release through two complementary pathways (GHRH + ghrelin receptor). Some protocols add IGF-1 LR3 for direct anabolic signaling. Any peptide stack should be discussed with a healthcare provider, as combining multiple growth-promoting peptides increases both effects and potential risks.
Peptides work primarily through the GH/IGF-1 axis, producing indirect, gradual anabolic effects. Anabolic steroids directly activate androgen receptors and are significantly more potent for acute muscle hypertrophy. Steroids carry greater risks including hormonal suppression, liver strain, and cardiovascular harm. Peptides generally have milder side effect profiles but less dramatic muscle-building results.
GH-releasing peptides typically require 3-6 months of consistent use alongside resistance training to produce noticeable changes in body composition. IGF-1 analogs may show effects sooner but carry higher risk. Muscle growth from peptides is gradual and depends heavily on training stimulus, nutrition, sleep, and individual hormonal status.